Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces the previous Revision: v3.6.3, signaling a minor update to the page template or content. It does not alter the study details or other user-facing information on the page.
    Difference
    0.1%
    Check dated 2026-07-25T16:54:54.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    A new Revision: v3.6.3 label was added to the page, replacing the previous v3.6.2 label.
    Difference
    0.1%
    Check dated 2026-07-04T08:16:18.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0 label. This indicates a new deployment of the page without changes to study data.
    Difference
    0.1%
    Check dated 2026-06-27T03:59:59.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The study page now displays that recruitment has ended, and new sections for How to Read a Study Record, Common Questions, and How to Join a Study have been added. Additionally, the label formatting for Intervention/Treatment was adjusted and the Revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T23:54:10.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5 on the page, indicating a new version of the page layout or content. This is a system-level update and does not reflect changes to the study data or visible content, but may include minor fixes or enhancements to the page.
    Difference
    0.1%
    Check dated 2026-06-05T21:38:22.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a new release or update to the page’s documentation. This change does not modify the study content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-05-15T14:35:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.